BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 20167788)

  • 1. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa.
    Srinivas N; Jetter P; Ueberbacher BJ; Werneburg M; Zerbe K; Steinmann J; Van der Meijden B; Bernardini F; Lederer A; Dias RL; Misson PE; Henze H; Zumbrunn J; Gombert FO; Obrecht D; Hunziker P; Schauer S; Ziegler U; Käch A; Eberl L; Riedel K; DeMarco SJ; Robinson JA
    Science; 2010 Feb; 327(5968):1010-3. PubMed ID: 20167788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics.
    Werneburg M; Zerbe K; Juhas M; Bigler L; Stalder U; Kaech A; Ziegler U; Obrecht D; Eberl L; Robinson JA
    Chembiochem; 2012 Aug; 13(12):1767-75. PubMed ID: 22807320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural studies of β-hairpin peptidomimetic antibiotics that target LptD in Pseudomonas sp.
    Schmidt J; Patora-Komisarska K; Moehle K; Obrecht D; Robinson JA
    Bioorg Med Chem; 2013 Sep; 21(18):5806-10. PubMed ID: 23932450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimicrobial activity against Pseudomonas aeruginosa of macrocyclic β-hairpin peptidomimetic antibiotics containing N-methylated amino acids.
    Vetterli SU; Moehle K; Robinson JA
    Bioorg Med Chem; 2016 Dec; 24(24):6332-6339. PubMed ID: 27240465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
    Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417
    [No Abstract]   [Full Text] [Related]  

  • 7. A peptide based on homologous sequences of the β-barrel assembly machinery component BamD potentiates antibiotic susceptibility of Pseudomonas aeruginosa.
    Mori N; Ishii Y; Tateda K; Kimura S; Kouyama Y; Inoko H; Mitsunaga S; Yamaguchi K; Yoshihara E
    J Antimicrob Chemother; 2012 Sep; 67(9):2173-81. PubMed ID: 22628248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics.
    Shankaramma SC; Athanassiou Z; Zerbe O; Moehle K; Mouton C; Bernardini F; Vrijbloed JW; Obrecht D; Robinson JA
    Chembiochem; 2002 Nov; 3(11):1126-33. PubMed ID: 12404639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence requirements and an optimization strategy for short antimicrobial peptides.
    Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
    Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism.
    Dosunmu EF; Chaudhari AA; Bawage S; Bakeer MK; Owen DR; Singh SR; Dennis VA; Pillai SR
    BMC Microbiol; 2016 Aug; 16(1):192. PubMed ID: 27549081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
    Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting back: peptidomimetics as a new weapon in the battle against antibiotic resistance.
    Bragonzi A
    Sci Transl Med; 2010 Mar; 2(21):21ps9. PubMed ID: 20374995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.
    Bezzerri V; Avitabile C; Dechecchi MC; Lampronti I; Borgatti M; Montagner G; Cabrini G; Gambari R; Romanelli A
    J Pept Sci; 2014 Oct; 20(10):822-30. PubMed ID: 25201563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice.
    Pan CY; Chao TT; Chen JC; Chen JY; Liu WC; Lin CH; Kuo CM
    Int Immunopharmacol; 2007 May; 7(5):687-700. PubMed ID: 17386416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic cationic β(3R3)-peptides: membrane active peptidomimetics and their potential as antimicrobial agents.
    Mosca S; Keller J; Azzouz N; Wagner S; Titz A; Seeberger PH; Brezesinski G; Hartmann L
    Biomacromolecules; 2014 May; 15(5):1687-95. PubMed ID: 24694059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
    Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa.
    Shang D; Meng X; Zhang D; Kou Z
    Biochem Pharmacol; 2017 Nov; 143():65-78. PubMed ID: 28756209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Peptidomimetic Antibiotic Interacts with the Periplasmic Domain of LptD from Pseudomonas aeruginosa.
    Andolina G; Bencze LC; Zerbe K; Müller M; Steinmann J; Kocherla H; Mondal M; Sobek J; Moehle K; Malojčić G; Wollscheid B; Robinson JA
    ACS Chem Biol; 2018 Mar; 13(3):666-675. PubMed ID: 29359918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.